Clinical context
Visual acuity alone is insufficient when judging corneal disease or surgery. Topography and tomography, surface regularity, biomechanics, endothelial cell density, quality of vision and stability all matter. After refractive procedures, epithelial healing, dry eye, haze, ectasia and the need for enhancement should be assessed separately.
What was studied
This retrospective study included 158 eyes with myopic regression after LASIK or PRK. Retreatment used LASIK in 136 eyes, PRK in 12 and a phakic ICL in 10. One eye per patient was analyzed. LASIK enhancement required no ectasia and an estimated residual stromal bed above 280 µm; PRK or ICL was considered when LASIK was unsuitable. Vision, spherical equivalent, efficacy, safety and complications were followed for 6–12 months.
How the evidence was produced
A cohort study describes how outcomes are associated with an exposure or treatment in an observed clinical population. This design is useful for routine practice, uncommon events and longer follow-up, but it remains vulnerable to confounding by indication, baseline risk differences and missing data. An association should not automatically be interpreted as a causal effect.
How to interpret the result
Selected patients regained useful uncorrected vision through different approaches. The study does not determine which method is best: ICL was used in ten eyes with greater regression, and selection depended on corneal suitability. Mean time to retreatment was 70.1 months for LASIK, 46.8 for PRK and 158.5 for ICL. Associations with age, initial refraction and ablation were weak, preventing reliable individual prediction.
The result should be understood as an estimate for the population studied, not a promise of an individual outcome. Statistical and clinical significance, absolute and relative effects, and prespecified and exploratory analyses should be distinguished. When several endpoints or subgroups are reported, the prespecified primary endpoint for which the study was designed usually provides the most reliable inference.
Clinical applicability
The study may refine technique selection and informed discussion, but its conclusions depend on baseline corneal shape, stromal thickness, equipment, nomogram and surgeon experience. Applicability requires comparison of these factors and attention to variability, uncommon complications and follow-up duration rather than mean values alone.
Limitations
The retrospective design and severely unbalanced groups create strong confounding by indication. Flap thickness and residual stromal bed were estimated from prior treatment parameters rather than postoperative OCT. Minimum eligible follow-up was one month although data extended to a year, so late completeness may differ. The source should be checked for follow-up by group, ICL selection, lens type and vault, epithelial-ingrowth management, haze severity, complication distribution and one author's manufacturer relationships.
Beyond the limitations acknowledged by the authors, confidence is affected by sample size, follow-up duration, missing data, choice of comparator and relevance of the outcomes to routine care. Uncommon complications may remain undetected even in a well-conducted study. External validity is reduced when participants, equipment or investigator expertise differ substantially from everyday settings.
What to verify in the source
In the full paper, verify the protocol, eligibility criteria, baseline group characteristics, primary endpoint definition, confidence intervals, adverse events and losses to follow-up. Funding, conflicts of interest, trial registration and consistency between the published analysis and the original plan deserve separate attention. The DOI or source link below provides access to the primary publication for this check.